Alphatec Holdings Inc. (ATEC), a leading medical equipment and supplies company, witnessed a significant surge in its stock price, soaring over 5% in pre-market trading on Thursday. This rally was fueled by the company's impressive fourth-quarter 2024 financial results and an optimistic outlook for the upcoming year.
In the fourth quarter of 2024, Alphatec achieved remarkable growth, with total revenue reaching $177 million, representing a 28% year-over-year increase and a 17% sequential growth. The company's surgical revenue grew by an impressive 28% year-over-year to $157 million, while its EOS revenue rose by 32% to $20 million. Furthermore, Alphatec reported positive free cash flow of $9 million for the first time since its transformation, a significant milestone for the company.
Looking ahead to 2025, Alphatec provided an optimistic revenue outlook, projecting approximately $732 million in revenue, reflecting a robust 20% growth rate. Additionally, the company forecasted an adjusted EBITDA of $75 million for the upcoming year. These positive financial projections, combined with the strong fourth-quarter performance, fueled investor confidence and drove the pre-market surge in Alphatec's stock price.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.